645 A novel eRF1 degrader induces translational readthrough of cystic fibrosis transmembrane conductance regulator nonsense mutations to therapeutically relevant levels in combination with aminoglycosides

Autor: Rowe, S., Chen, J., Du, M., Li, Y., Peng, N., Tang, L., Mutyam, V., Sharma, J., Thrasher, K., Fu, L., Liu, K., Mathew, B., Rodzinak, K., Bostwick, R., Keeling, K., Suto, M., Augelli-Szafran, C., Bedwell, D.
Zdroj: In Journal of Cystic Fibrosis October 2022 21 Supplement 2:S354-S354
Databáze: ScienceDirect